Steroid-Induced Hiccups in a Patient Managed for Pseudo Foster-Kennedy Syndrome: A Case Report of Good Outcome With the use of Gabapentin

The use of IV methylprednisolone has been shown to be associated with some adverse effects. The most feared side effect is acute gastrointestinal perforation and accelerated hypertension particularly during pulse therapy. Hiccups occur less frequently but can cause high levels of discomfort to the patient. In intractable cases, respiratory arrest and death can occur. This article reports the occurrence of hiccups in a patient managed for pseudo Foster-Kennedy syndrome. The hiccups were observed shortly after IV methylprednisolone was administered to the patient and abetted over a period of one week after it was discontinued. Hiccups occur through the neuronal pathway of the hiccup reflex arc, comprising the vagus nerve, phrenic nerve, parts of the sympathetic nervous system (T6-T12), and efferent fibers from the phrenic nerve that supply the glottis and the accessory muscles of respiration. The hiccups resolved with the use of gabapentin. This case report aims to add to the existing body of knowledge of the efficacy of gabapentin in the management of hiccups.

[1]  Chukwuemeka Okorie Eze,et al.  Persistent Hiccups Following Use of Oral Dexamethasone: A Report of Two Cases from Abakaliki, Nigeria , 2020 .

[2]  Cheng Yang,et al.  Intractable hiccups as a rare gastrointestinal manifestation in severe endocrine and metabolic crisis: case report and review of the literature , 2020, Therapeutic advances in endocrinology and metabolism.

[3]  E. Bruera,et al.  Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial. , 2017, The oncologist.

[4]  M. Hollmann,et al.  Chronic Hiccups: An Underestimated Problem , 2017, Anesthesia and analgesia.

[5]  P. Baker,et al.  Management of hiccups in palliative care patients , 2017, BMJ Supportive & Palliative Care.

[6]  S. Lakhan,et al.  Neurotransmitters in hiccups , 2016, SpringerPlus.

[7]  Olga Hilas,et al.  Gabapentin for the treatment of persistent hiccups. , 2014, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

[8]  M. Peacock Transient Hiccups Associated with Oral Dexamethasone , 2013, Case reports in dentistry.

[9]  P. Wiffen,et al.  Interventions for treating persistent and intractable hiccups in adults. , 2013, The Cochrane database of systematic reviews.

[10]  F. Chang,et al.  Hiccup: Mystery, Nature and Treatment , 2012, Journal of neurogastroenterology and motility.

[11]  C. Ficorella,et al.  Gabapentin in the Treatment of Hiccups in Patients With Advanced Cancer: A 5-Year Experience , 2010, Clinical neuropharmacology.

[12]  C. Ramos-Estebanez,et al.  Gabapentin for intractable hiccup. , 2004, The American journal of medicine.

[13]  Howard S. Smith,et al.  Management of hiccups in the palliative care population , 2003, The American journal of hospice & palliative care.

[14]  J. Kocsis,et al.  A summary of mechanistic hypotheses of gabapentin pharmacology , 1998, Epilepsy Research.

[15]  J. Tubiana,et al.  Intractable hiccups: the role of cerebral MR in cases without systemic cause. , 1995, AJNR. American journal of neuroradiology.